FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Idaho bar owner faces death threats after viral promo offering free beer for assisting ICE

Judge rules evidence linked to James Comey’s ally is off limits to DOJ

EXCLUSIVE: Trump-led Kennedy Center nearly doubles fundraising from Biden era, smashing record with $23M haul

Hegseth hints at major defense spending hike, reveals new details on Trump’s anti-narco-terrorism operations

Hegseth hints major defense spending increase, reveals new details on Trump’s anti-narcoterrorism operations

Dr. Oz warns Walz to address alleged Somali Medicaid fraud or lose federal funding: ‘We’ll stop paying’

Disgraced teacher accused of using Google Docs to groom underage student before alleged sex crimes

Louisiana manhunt continues as dangerous inmate charged with attempted murder remains on the run

Photos: Incredibly Creepy New Epstein Island Photos Released – Chilling Masks, Eerie Dentist Chair, Weird Writing on Chalkboard

This week in Campus Radicals: Christian student flunked, Jewish students shaken, conservative groups blocked

Fact Check: Do Somalis Contribute More to Minnesota’s Bottom Line Than They Take?

Mass killings fall to lowest level in nearly two decades, national database shows

Amid Billion-Dollar Somali Fraud Scandal, Minn. Gov. Tim Walz Reveals What He’s ‘Deeply Concerned’ About: Trump Insult

Unhinged Maxine Waters’ Latest Preposterous Allegation: Trump Is a ‘Killer’

Biden, Man Dems Said Could Serve Four More Years as President, Cannot Pronounce Name of His Own Country

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”